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Background: There is evidence that psychological therapies including cognitive behaviour therapy (CBT) may
be effective in reducing postnatal depression (PND) when offered to individuals. In clinical practice, this is
also implemented in a group therapy format, which, although not recommended in guidelines, is seen as a
cost-effective alternative. To consider the extent to which group methods can be seen as evidence-based,
we systematically review and synthesise the evidence for the efficacy of group CBT compared to currently
used packages of care for women with PND, and we discuss further factors which may contribute to clinician
confidence in implementing an intervention.
Methods: Seventeen electronic databases were searched. All full papers were read by two reviewers and a third
reviewer was consulted in the event of a disagreement on inclusion. Selected studies were quality assessed,
using the Cochrane Risk of Bias Tool, were data extracted by two reviewers using a standardised data extraction
form and statistically synthesised where appropriate using the fixed-effect inverse-variance method.
Results: Seven studies met the inclusion criteria. Meta-analyses showed group CBT to be effective in reducing
depression compared to routine primary care, usual care or waiting list groups. A pooled effect size of d = 0.57
(95% CI 0.34 to 0.80, p < 0.001) was observed at 10–13 weeks post-randomisation, reducing to d = 0.28 (95% CI
0.03 to 0.53, p = 0.025) at 6 months. The non-randomised comparisons against waiting list controls at 10–13 weeks was
associated with a larger effect size of d = 0.94 (95% CI 0.42 to 1.47, p < 0.001). However due to the limitations of the
available data, such as ill-specified definitions of the CBT component of the group programmes, these results should be
interpreted with caution.
Conclusions: Although the evidence available is limited, group CBT was shown to be effective. We argue, therefore,
that there is sufficient evidence to implement group CBT, conditional upon routinely collected outcomes being
benchmarked against those obtained in trials of individual CBT, and with other important factors such as patient
preference, clinical experience, and information from the local context taken into account when making the treatment
decision.Background
Postnatal depression (PND) is defined as a non-psychotic
depressive episode meeting standardised diagnostic cri-
teria for a minor or major depressive disorder beginning
in or extending into the postnatal period [1]. It is a major
health issue for the affected individual and represents a
significant risk to her child. PND has a substantial impact* Correspondence: A.Scope@sheffield.ac.uk
1School of Health and Related Research (ScHARR), The University of Sheffield,
30 Regent Street, Sheffield S1 4DA, UK
Full list of author information is available at the end of the article
© 2013 Scope et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the oron the mother and her partner [2] and the family [3]. It
may result in impaired maternal-infant interactions, [4]
can lead to attachment insecurity, [5] impaired cognitive
[6] and social-emotional development [7].
Prevalence estimates of 14.5% for developed countries
[8] and 13% for developing countries [9] make PND an
important global issue, although many cases may go un-
detected [10]. PND usually develops within the first three
postnatal months, [11] with a peak incidence at around 4–
6 weeks [1]. Although one study showed that most epi-
sodes last around three months and resolve spontaneouslytd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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presence of depression lasted over six months in over 50%
of the sample, and in some cases depression was still
present at four years [12].
The current National Institute for Health and Clinical
Excellence (NICE) clinical guideline for antenatal and
postnatal mental health [13] outlines the recommended
care pathway to identify and treat women with PND,
[13] although services vary widely across the UK. NICE
guidance recommends psychological interventions such
as individual cognitive behaviour therapy (CBT) or inter-
personal therapy (IPT) for women with PND. However,
the difficulty for practitioners in offering psychological
interventions is that a number of potentially useful treat-
ments may not meet the requirements of evidence-based
practice (EBP) if it is applied in its strictest sense. The
case example used here is whether it is effective to offer
CBT in a group format.
Evidence-based practice (EBP) is defined as ‘the con-
scientious, explicit, and judicious use of current best evi-
dence in making decisions about the care of individual
patients. The practice of evidence based medicine means
integrating individual clinical expertise with the best
available external clinical evidence from systematic re-
search’ [14]. However, in some instances psychological
therapies struggle to meet the demands of EBP as psy-
chological and social aspects of treatments are often not
taken into account [15]. The narrow ’single diagnosis,
single intervention’ approach to evidence-based practice
is in contrast with the broader appraisal clinicians need
to make regarding psychological therapies. Factors other
than the specific therapy method (e.g. CBT, IPT or psy-
chodynamic) influence clinical outcomes, including the
patient and the therapist forming a good working rela-
tionship, treatment length, patient demographics, patient
preference, the skill level of therapist, and patient char-
acteristics [16]. Medical Research Council (MRC) guide-
lines on trials for complex interventions recommend the
need to look at the ‘practical effectiveness’ of interven-
tions, i.e. whether an intervention works in everyday
practice [17]. Guidelines, even when supported by the
best implementation practices, need to be supplemented
by other clinical support methods and with methods of
monitoring what is actually done in practice and its im-
pact on the patient [18]. This includes exploring how ef-
fects may vary among recipients, and how this variation
may be explained. Verkerk et al. [19] highlight the vari-
ability in the reported effectiveness of psychological in-
terventions designed to reduce the risk of PND. They
suggest that this variability may in part be explained by
patient-related factors such as personality or patient pref-
erence for psychosocial intervention aimed at improving
postnatal psychological adjustment. Further consideration
of this is provided by Scope et al. [20]. This was a reportof a systematic review that aimed to synthesise qualitative
evidence relating to women’s perceptions and experiences
of group cognitive behaviour therapy and other group in-
terventions for postnatal depression. This study showed
that women have contrasting experience of such treat-
ments and that attention should be given to selecting pa-
tients for whom group treatment is most likely to be
beneficial.
As there is an urgent need for effective treatments to
prevent the poor outcomes of PND [10] it is important
to assess potentially useful treatments in this broader
context. While antidepressant medication has been
validated as an effective treatment for general depres-
sion, mothers who are breastfeeding are often reluctant
to take medication due to possible transmission of
unwanted effects through breast milk [21]. Similarly, in
a randomized controlled trial (RCT) comparing anti-
depressant medication (Fluoxetine) with cognitive-
behavioural counselling in women with PND [22] the
main reason for non-participation in the study was a
reluctance to take antidepressant medication. It there-
fore seems imperative that non-pharmacological inter-
ventions are developed and evaluated and consensus is
obtained about them. CBT is widely used for the treat-
ment of PND and evidence supports its use in the
treatment of mild to moderate non-childbirth related
depression [23].
A large range of treatment trials, some involving group
treatment, have been reported in earlier systematic re-
views of women with PND [24,25]. A total of 21 studies
were extracted including IPT, CBT, peer and partner
support, infant sleep interventions, relaxation/massage
therapy, maternal exercise, nondirective counselling, and
infant-mother relationship therapy [24]. Overall no def-
inite conclusions were reached about the relative effect-
iveness of many non-biological treatment approaches
due to the lack of high quality investigations. In a review
of psychosocial and psychological interventions for treat-
ing postpartum depression, Dennis and Hodnett [26]
concluded that individual-based strategies were effective
in decreasing depressive symptomatology. However, only
one included study examined group-based interventions,
therefore no conclusions could be drawn regarding this
mode of delivery.
Although psychological interventions such as CBT are
recommended for PND, access to individual CBT may
be limited and group CBT treatment may be a potential
alternative. This has the potential to reduce cost, therap-
ist time, waiting time and to increase the number of
available places. Patients are treated in groups of around
eight people and treatment usually runs for 12 weeks
often preceded by one individual session. There is little
available evidence on the service provision of group
CBT specifically for PND. There were two objectives of
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thesise the evidence for effectiveness of group CBT com-
pared to currently used package of care for women with
PND, as measured by change in depression, and the sec-
ond was to discuss other factors which may contribute
to clinician confidence in implementing an intervention.
Methods
This paper is an update of a review published as part of an
HTA monograph. It adds to the findings reported in the
monograph by updating the searches and conducting
meta-analyses of the available evidence. A full description
of the sources searched and more detailed information on
excluded papers is described in Stevenson 2010 [27]. The
search strategy was developed, and the search conducted,
by an information specialist (AC). The searches aimed to
identify all references relating to the clinical effectiveness
of group CBT for PND. Seventeen electronic bibliographic
databases were searched including: Medline, CINAHL,
Cochrane, Embase and PsycINFO. The reference lists of
relevant articles were checked and various health services
related resources were consulted via the Internet. Grey lit-
erature searches were also undertaken using sources such
as dissertation abstract databases. Population search terms
included: depression, postpartum, postnatal depression,
and post pregnancy depression. Searches were not re-
stricted by intervention due to the complexity of defining
the intervention and to prevent omission of relevant refer-
ences. Searches were not restricted by language but non-
English language papers were excluded at the sifting stage.
Searches were undertaken in January 2008 and databases
searched from 1950–2008. An update search, replicating
the original search, was performed in March 2011. Data-
bases were searched from 2008 to March 2011.
We included studies with populations that included
women meeting the criteria of a standardized PND diag-
nosis using the diagnostic and statistical manual (DSM-
IV) [28] or were screened for PND using the EPDS. If a
clinical diagnosis is given, DSM-IV criteria for depressive
disorder were used. DSM-IV recognises PND as a form of
general depression with a specifier coded ‘postpartum de-
pression’ if it occurs within four week after giving birth.
Some studies reported other measures of PND in addition
to DSM-IV or EPDS. However, DSM-IV diagnosis or
PND identified using the EPDS are the usual entry criteria
for treatment programmes. Prenatal women, women with
other comorbid psychiatric disorders or major medical
problems or women who had been involved in a previous
psychological programme were excluded. All interventions
with elements deriving from cognitive behavioural princi-
ples were included, including those which were “psycho-
educational” and in a group. All settings were included
and all comparators considered including routine primary
care, waiting list, individual CBT, group based counselling,medication, group behaviour therapy and group IPT.
Studies were included if they reported depression mea-
sured using the Edinburgh Postnatal Depression Scale
(EPDS) [29] or the Beck Depression Inventory (BDI)
[30]. The EPDS is the most widely used self-report scale
for the identification of PND. Whilst the EPDS was de-
veloped specifically to measure PND, PND may also be
measured using the BDI which is a general population
depression scale.
Papers were assessed according to the accepted hier-
archy of evidence with systematic reviews of RCTs taken
as the most authoritative forms of evidence and uncon-
trolled observational studies the least authoritative [31].
All full papers were read and quality assessed by two
reviewers and a third reviewer was consulted in the
event of a disagreement on inclusion or quality. In-
cluded papers were quality assessed using the Cochrane
Risk of Bias Tool [32]. The quality elements addressed
included selection bias (randomisation), reporting bias
(outcome measures), attrition bias (ITT analysis), and
detection bias (blinding of assessors). All data from
included studies were extracted by two reviewers using
a standardised data extraction form. Both RCTs and
non-RCTs were considered for data synthesis. Data re-
lating to each study’s key characteristics (e.g. popu-
lation, intervention type and duration) and pertinent to
the research question (i.e. clinical effectiveness) were
extracted. The main outcome measure of interest was
self-reported depression following intervention using
either the BDI or the (EPDS).
Comparisons were quantified by standardised mean dif-
ferences (SMDs) in which the effect size are presented in
units of the standard deviation [33]. Statistical heterogen-
eity was quantified by the I2 statistic and formally tested
by Cochran’s Q statistic. Where appropriate, studies were
combined using the fixed-effect inverse-variance method.
All analyses were undertaken using the metan [34] com-
mand within the Stata statistical package.
Results
From the original searches we screened 7633 references
and assessed the text of 153 full papers. The update
search produced 2547 references which were screened
and the text of 56 full papers was assessed. The study se-
lection and exclusion process are summarised in Add-
itional file 1: Figure S1. Six studies met the inclusion
criteria from the original search, and the update search
produced one additional study. The overall quality of the
studies was low with a risk of bias in a number of do-
mains, particularly for the non-RCTs as would be ex-
pected. Only two studies (both non-RCTs) reported
reasons for loss to follow-up, only two studies reported
using a power calculation, and only two reported that
the outcome assessor had been blinded. Furthermore
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analyses.
The studies all included a group programme which in-
corporated some level of CBT theory or technique, al-
though the degree of incorporation of CBT theory or
technique varied markedly between studies. Three studies
[35-37] specifically refer to at least a CBT component
which appears to be a core-pre-defined aspect of the treat-
ment. This however cannot be claimed with certainty for
the Highet and Drummond [35] study due to a lack of de-
tail in the report. The definitions in the other four in-
cluded studies [38-41] are somewhat ill-specified and it is
unclear whether CBT is a core aspect of the group
treatment.
The study characteristics of the seven included studies
are described in Table 1. The key components of study
quality assessment are listed in Additional file 1: Figures
S2 and S3.
Three of the included studies were RCTs [36,37,41]
and four were non-randomised studies [35,38-40]. All
seven studies had at least one comparison arm. Six of
the studies compared group CBT to routine primary
care or wait list group [36-41] although definitions of
the interventions varied across studies. One non-RCT
[35] compared group CBT to individual CBT and one
[38] to IPT. One RCT [37] compared group CBT to
group counselling and individual counselling.
Study characteristics
Participants in the RCTs were recruited from commu-
nity screening programmes of newly delivered mothers
or referred by health visitors. For the non-RCTs recruit-
ment was through health care provider referrals, news-
paper advertisements and through advertisements in
local hospitals and maternal and child health centres.
One non-RCT [35] was a retrospective study of women
who sought or had been referred for PND treatment.
Study quality
Although the three RCTs reported the number of partic-
ipants lost to follow-up, none provided the reasons for
loss to follow-up. Two of the three non-RCTs reported
the reasons for loss to follow-up, these included physical
illness and difficulty in organising attendance [40] and
not being contactable post-treatment, not considered to
have PND by their healthcare provider, refusal to take
part in the study, and stopping treatment prior to com-
pletion [37]. Follow-up exceeded 60% in all studies.
An acceptable method of randomisation was reported
in all three RCTs. Although blinding of participants was
not possible due to the nature of the intervention, two
studies reported that the outcome assessor had been
blinded [37,41] and two [37,41] reported power calcula-
tions. For the three non-randomised studies the studyquality varied considerably. Participants included in the
Meager and Milgrom [40] study were randomly assigned
to either the group treatment or a wait-list group, but
no randomisation method was reported. The Highet and
Drummond [35] study examined patient records and no
randomisation had taken place. In the Clark et al.
[38,39] studies sequential assignment to group treatment
or to the wait list was performed on the basis of
matching for sociodemographic variables. None of the
non-RCTs reported blinded assessment or a power
calculation. Clark et al. [38] did not include all study
participants in their analyses, with data only analysed
for those participants with BDI scores of 16 or higher.
Psychological outcomes
Three studies reported depression scores using the EPDS
[35,36,42] and three reported BDI scores, [37-39] with
the final study reporting scores for both scales [40]. For
six of the seven studies the main outcomes related to
improvement in depression symptoms. However, Clark
et al. [38] reported infant development as the main out-
come. Meta-analyses were conducted for depression out-
comes Table 2.
Means and standard deviations (SDs) were obtained
directly from the papers where reported. In Rojas, [41]
SDs were derived from 95% confidence intervals. Meager
[40] did not report SDs, but these could be estimated
from means and the p-value for their comparison.
Three studies, all RCTs, compared group CBT to usual
care. Rojas [41] and Honey [36] assessed depression using
the EPDS at 3 and 6 months post-randomisation, whereas
Milgrom [37] used the BDI. Four non-randomised studies
compared group CBT versus waiting list. Clark [38] and
Clark [39] evaluated depression using BDI at 12 week post-
randomisation, and Meager [40] used both BDI and EPDS
to evaluate depression 10 weeks post-randomisation. The
fourth study [35] was not considered for synthesis as treat-
ment groups were not mutually exclusive.
These studies enabled meta-analyses to be performed
among three subgroups: i) group CBT versus usual care
between 10–13 weeks; ii) group CBT versus usual care
at 6 months; and iii) group CBT versus waiting list be-
tween 10–13 weeks. The results are displayed graphically
in Figure 1. In subgroup iii), Meager [40] was included
using the BDI outcome data as this was the measure
used by other studies in this subgroup, although results
obtained using the EPDS were very similar. The I2 was
equal to zero in all subgroups.
Group CBT was associated with improved outcomes
in all three subgroups. A pooled effect size of d = 0.57
(95% CI 0.34 to 0.80, p < 0.001) was observed at 10–
13 weeks post-randomisation, reducing to d = 0.28 (95%
CI 0.03 to 0.53, p = 0.025) at 6 months. The non-
randomised comparisons against waiting list controls at
Table 1 Summary of study characteristics for the seven included studies
First
author,
date
(country)
N Design Intervention Concurrent
therapy
Comparator Number/
duration
of
sessions
Measure/
timescale
Summary of main outcomes
Rojas 2007
(Chile)
I: 114 RCT Multi-Component Intervention including
psychoeducational group and structured
pharmacology if needed
Yes Usual Care 8 x 50
minute
weekly
sessions
EPDS Greater improvement in EPDS over three months in the
intervention group, with differences between groups
remaining at six months, although decreasedC: 116
Milgrom
2005
(Australia)
I: 46 RCT Group-based Cognitive-Behavioural Therapy.
Including psychoeducation, role-playing and
discussion
N/R C1: Group-
based
counselling
9 x 90
minute
weekly
sessions
BDI Significantly greater reduction in depression scores after all
interventions compared to routine primary care
C1: 47 C2: Individual
Counselling
C2: 66 C3: Routine
Primary Care
C3: 33
Honey
2002 (UK)
I: 23 RCT Controlled Psychoeducational Group (PEG).
Educational information on post-natal depres-
sion, strategies for coping, cognitive-
behavioural techniques
N/R Routine
Primary Care
8 x
2 hour
weekly
sessions
EPDS Significantly greater reduction in depressive symptoms in
intervention group compared to routine primary care
C: 22
Highet
2004
(Australia)
I: 136 Non RCT Eight different, not mutually exclusive,
treatment groups
Yes Waiting List N/R EPDS Significant decrease in depression for those in intervention
groups compared to those in the waiting list group
C: 10
Clark 2003
(US)
I: 13 Non RCT Mother-Infant Therapy Group. Based on
interpersonal, psychodynamic, family systems
and cognitive-behavioural approaches
N/R C1: Individual
Interpersonal
Therapy
12 x 90
minute
weekly
sessions
BDI No significant difference in reduction of depressive symptoms
for intervention group on BDI. No superiority of group therapy
over individual therapy but both show greater improvement
than control on CES-D
CES-D
C1: 15 C2: Waiting List
C2: 11
Clark 2008
(US)
I: 18 Non RCT Mother-Infant Therapy Group. Interpersonal,
psychodynamic, family systems, and cognitive
behavioural approaches
N/R Waiting List 12 x 120
minute
weekly
sessions
BDI Significantly greater improvement in depressive symptoms for
intervention group compared to waiting list group
C: 14
Meager
1996
(Australia)
I: 10 Non RCT Group Treatment. Social and emotional
support, education component, cognitive-
behavioural component, networking and
communication
Yes Waiting List 10 x 90
minute
weekly
sessions
BDI Significant improvement in depression in intervention group
compared to waiting list group
EPDSC: 10
Abbreviations: RCT Randomised Controlled Trial, NR Not reported, BDI Beck Depression Inventory, EPDS Edinburgh Postnatal Depression Scale, I Intervention, C Comparator.
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Table 2 Psychological outcome results by measure and follow-up time
Intervention group Control group
Author N Mean SD N Mean SD Comparison
BDI – 3 months
Milgrom (2005) 31 14.48 8.8 18 18.78 8.5 RCT v usual care
Clark (2003) 9 15.9 8.5 11 20.6 9.2 non-RCT v waiting list
Clark (2008) 18 12.42 7.08 14 20.5 7.27 non-RCT v waiting list
Meager (1996) 6 16.8 10 6 29.14 10 non-RCT v waiting list
EPDS – 3 months
Rojas (2007) 101 8.5 6.41 108 12.8 6.92 RCT v usual care
Honey (2002) 23 14.87 5.97 22 16.95 5.44 RCT v usual care
EPDS – 6 months
Rojas (2007) 106 10.9 6.67 102 12.5 6.92 RCT v usual care
Honey (2002) 23 12.55 4.62 22 15.63 7.28 RCT v usual care
Meager (1996) 6 15.8 7.6 6 28 7.6 non-RCT v waiting list
Abbreviations: BDI Beck Depression Inventory, EPDS Edinburgh Postnatal Depression Scale, RCT Randomised Controlled Trial.
Footnote: The total range of EPDS scores is 0–30. Scores within the range 12–30 suggest clinically significant depression. The total range of BDI scores is 0–63.
Scores within the 1–9 range indicate minimal depression, 10–18 mild depression, 19–29 moderate depression, and 30–63 severe depression.
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d = 0.94 (95% CI 0.42 to 1.47, p < 0.001).
Discussion
Seven comparative studies were identified in this re-
view. Meta-analyses show that group CBT appeared toRCTs of group CBT versus usual care, 10-13 weeks
Milgrom (2005) *
Honey (2002)
Rojas (2007)
Subtotal  (I-squared = 0.0%, p = 0.699)
RCTs of group CBT versus usual care, 6 months
Honey (2002)
Rojas (2007)
Subtotal  (I-squared = 0.0%, p = 0.415)
non-RCTs of group CBT versus waiting list
Clark (2003)
Clark (2008)
Meager (1996)
Subtotal  (I-squared = 0.0%, p = 0.533)
Author
Favours group CBT  
-2.5 -2 -1.5 -1 -.5
Figure 1 Forest plot to show meta-analyses for three subgroups: i) gr
versus usual care at 6 months; and iii) group CBT at versus waiting lis
are calculated from EPDS scale with the exception of * which used BDI invbe clinically effective when compared to routine primary
care, usual care or a waiting list group, although the reduc-
tion in depression scores was not consistent across time.
These results should be interpreted with caution due to
the limited number and quality of the studies. In addition,
some of the included studies included concurrent therapy,-0.49 (-1.08, 0.09)
-0.36 (-0.95, 0.23)
-0.63 (-0.91, -0.35)
-0.57 (-0.80, -0.34)
-0.51 (-1.10, 0.09)
-0.24 (-0.51, 0.04)
-0.28 (-0.53, -0.03)
-0.53 (-1.43, 0.37)
-1.13 (-1.88, -0.37)
-1.23 (-2.49, 0.02)
-0.94 (-1.47, -0.42)
Cohen's d (95% CI)
15.40
15.39
69.21
100.00
17.41
82.59
100.00
34.15
48.35
17.50
100.00
Weight
Favours control 
0 .5 1
oup CBT versus usual care between 10–13 weeks; ii) group CBT
t between 10–13 weeks. Footnote: Effect sizes in subgroups i) and ii)
entory. Effect sizes in subgroups iii) used BDI inventory.
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treatment.
There was uncertainty as to how some of the described
group treatments accurately reflect CBT and whether gen-
eralisations can be made due to participants being at dif-
ferent times postpartum in some studies. There is enough
doubt in the quality, the level of CBT implemented in the
group programmes, and the applicability to a PND popu-
lation to limit any interpretations significantly. There is
also debate over the comparability of the two measures
used to evaluate PND, with some authors suggesting the
generic BDI and PND-specific EPDS instruments are
measuring intrinsically different features (e.g. Huffman,
Lamour, Bryan, & Pederson, 1990; [43,44] Horowitz,
Damato, Solon, Metzch, & Gill, 1995 [45]) Nonetheless,
whilst the patient populations, CBT delivery and assess-
ment tools may be very different, the outcomes observed
in the meta-analyses were consistent with low I-squared
values in all cases.
Although definitions of EBP acknowledge the import-
ance of clinical expertise [14], and despite MRC recom-
mendations for complex interventions to look at ‘practical
effectiveness’, the emphasis is still on RCTs and meta-
analysis evidence. Patient preference factors together with
clinical experience may be just as important in the treat-
ment decision. The limitations of RCT evidence on psy-
chological therapies in making treatment decisions have
been extensively discussed [46,47]. These include the ex-
clusion of patients with co-morbid diagnoses, mixed diag-
noses, multiple or diagnoses which are not clearly defined
and patients who drop-out of treatments. Further, reasons
for such drop-outs and the data from patients who do
drop out may be particularly important in the evaluation
of psychological therapies. The quality of the primary
studies included in this review, and the fact that only
three RCTs have been reported, emphasise the problems
of relying on RCT research evidence alone to make de-
cisions about treatment of patients using psychological
therapies. It has been argued that such evidence needs
to be supplemented by practice-based evidence to yield
a more robust, relevant, reliable, and comprehensive
knowledge base [48].
One practical approach to this would be, where local
circumstances make it unfeasible to offer individual ther-
apies to all women with PND, to offer group methods
whilst monitoring routine outcomes, which can then be
benchmarked against the recovery rates obtained in tri-
als of individual CBT. Such an approach raises logistic,
methodological and ethical issues which we shall briefly
consider here.
Increasingly, psychological service providers monitor
outcomes of therapy routinely using standardised, patient-
reported measures; typically either condition-specific mea-
sures or more generic or global measures which spanwell-being, psychological distress and functioning. The
most commonly used measure for post-natal depres-
sion is EPDS; generic measures include CORE-OM and
OQ-45. The two logistic challenges are a) ensuring that
endpoint data are collected from all service users in-
cluding those who leave before the end of therapy and
b) that data are of sufficient quality for analysis. Data
completeness in routinely collected datasets typically
varies between sites; in one UK dataset of primary care
psychological therapy and counselling services, pre-
post completion rates varied between 3% and 99% for
the poorest and best performing service, with an aver-
age of 39% (sd = 23) [49]. This demonstrates that it is
possible with adequate care and attention to achieve
very high levels of data completeness, but that this
must be addressed vigorously. Ensuring data are of
good quality again implies that local services pay close
attention to how the measures are administered; for
comparability with research-based data, it is preferable
that questionnaires be administered outside the con-
sulting room in a confidential setting.
Benchmarking service outcomes using group CBT
against research trial reports using individual CBT should
follow the method outlined by Minami et al., [50] which
consists of three stages: constructing pre-post benchmarks
from relevant clinical trials in terms of effect sizes or re-
covery rates, estimating the effectiveness of routine prac-
tice. again in terms of effect size or recovery rate, and
comparing the routine practice effect size against the trials
benchmark. Cohen’s rule of d = 0.2 is applied as the mar-
gin around the clinical benchmark. Some methodological
and clinical issues surrounding this process are outlined
by Lueger and Barkham [51]).
Ethical issues are raised by implementing a group ther-
apy method without strong RCT evidence to support it,
particularly where an individual approach may be more
acceptable to patients. For example, in a comparison of
the acceptability of group vs individual CBT for panic
disorder and agoraphobia, Sharp, Power and Swanson
[52] found that when given a free choice of group or in-
dividual CBT at the end of the waiting list period, the
overwhelming majority (95%) of the waiting list patients
chose individual CBT. It could therefore be argued that
it is ethically more acceptable to offer group therapy as
an alternative to no therapy, where individual CBT is
not available to all women with PND.
Further research is needed to compare group CBT
with routine primary care, which is likely to be in the
main medication based with individual treatment and
with other psychological therapies. In addition, particu-
lar aspects of group treatment require assessment such
as the effect of the size of the group of patients, the
duration of the sessions, the setting, the qualifications
and optimal level of involvement of the facilitator. The
Scope et al. BMC Psychiatry 2013, 13:321 Page 8 of 9
http://www.biomedcentral.com/1471-244X/13/321review also highlights a need to assess the findings re-
ported here in tandem with those reported on patient
acceptability for this treatment [20] and for further re-
search on the acceptability of group CBT to patients
compared with alternative approaches.
Conclusion
Although the evidence available is limited and of poor
quality, we argue that, taken together with other import-
ant factors such as patient preference, there is sufficient
evidence to implement group CBT conditional upon
routinely collected outcomes being benchmarked against
those obtained in trials of individual CBT.
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